ROLE OF ARL6IP5 IN HCV-RELATED HEPATOCELLULAR CARCINOMA

被引:0
作者
Hu, Z. [1 ,2 ]
Wilson, G. S. [1 ]
George, J. [1 ]
Qiao, L. [1 ]
机构
[1] Univ Australia, Fac Med, Western Clin Sch, Med,Storr Liver Ctr,Westmead Millennium Inst Med, Westmead, NSW, Australia
[2] Lanzhou Univ, Hosp 1, Gastroenterol & Hepatol, Lanzhou 730000, Peoples R China
关键词
D O I
10.1016/S0168-8278(15)30442-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P0223
引用
收藏
页码:S390 / S391
页数:2
相关论文
共 50 条
[31]   HEPATOCELLULAR PROLIFERATION IN HCV-RELATED CHRONIC HEPATITIS [J].
FARINATI, F ;
CARDIN, R ;
DERRICO, A ;
GRIGIONI, W ;
MARAFIN, C ;
DEMARIA, N ;
CECCHETTO, A ;
NACCARATO, R .
GASTROENTEROLOGY, 1995, 108 (04) :A1063-A1063
[32]   Helicobacter Infection in Patients with HCV-Related Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma [J].
Maria P. Dore ;
Giuseppe Realdi ;
Daniela Mura ;
David Y. Graham ;
Antonia R. Sepulveda .
Digestive Diseases and Sciences, 2002, 47 :1638-1643
[33]   Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma [J].
K. Hamdy ;
R. Al Swaff ;
H. A. Hussein ;
M. Gamal .
Journal of Endocrinological Investigation, 2015, 38 :1225-1231
[34]   Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma [J].
Hamdy, K. ;
Al Swaff, R. ;
Hussein, H. A. ;
Gamal, M. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2015, 38 (11) :1225-1231
[35]   CELL-FREE DNA IN HCV-RELATED CIRRHOSIS AND SMALL HEPATOCELLULAR CARCINOMA [J].
Sampietro, Maurizio ;
Fracanzani, Anna Ludovica ;
Valenti, Luca ;
Bertelli, Cristina ;
Fatta, Erika ;
Bignamini, Daniela ;
Tavazzi, Dario ;
Fargion, Silvia .
HEPATOLOGY, 2008, 48 (04) :965A-965A
[36]   IMPACT OF OCCULT HBV INFECTION IN HEPATOCELLULAR CARCINOMA PRESENTATION IN HCV-RELATED CIRRHOSIS [J].
Coppola, N. ;
Iodice, V. ;
Starace, M. ;
Minichini, C. ;
Farella, N. ;
Onorato, L. ;
Liorre, G. ;
Sagnelli, E. ;
De Stefano, G. .
JOURNAL OF HEPATOLOGY, 2016, 64 :S374-S374
[37]   Circulating miR-485-5p as a potential diagnostic and prognostic biomarker for HCV-related hepatocellular carcinoma [J].
Elgedawy, Gamalat A. ;
Elabd, Naglaa S. ;
Elbrolosy, Asmaa M. ;
El-Morshedy, Suzan M. ;
El-Gamal, Ayman ;
Abozeid, Mai ;
Abdelkreem, Mervat ;
Eleowa, Sama S. ;
Helal, Marwa L. .
CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)
[38]   Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma [J].
Toraih, Eman A. ;
Ellawindy, Alia ;
Fala, Salma Y. ;
Al Ageeli, Essam ;
Gouda, Nawal S. ;
Fawzy, Manal S. ;
Hosny, Somaya .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 :653-669
[39]   Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis [J].
Mazzella, G ;
Accogli, E ;
Sottili, S ;
Festi, D ;
Orsini, M ;
Salzetta, A ;
Novelli, V ;
Cipolla, A ;
Fabbri, C ;
Pezzoli, A ;
Roda, E .
JOURNAL OF HEPATOLOGY, 1996, 24 (02) :141-147
[40]   lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma [J].
Zhang, Chun ;
Yang, Xi ;
Qi, Quan ;
Gao, Yuhai ;
Wei, Qiang ;
Han, Shuwen .
CANCER BIOMARKERS, 2018, 21 (03) :651-659